and legal reforms: Gateway to innovation and global integration -- Chapter 3: The golden age of the Chinese biopharma …: Explosive growth in a thriving ecosystem -- Chapter 4: Innovation in the Chinese biopharma: From me-too to First … country with no innovation in drug discovery, to a country which starts to out-license its biopharma technology to the rest of …

innovation. The book is extensively researched and provides compelling insights for IPR managers, technology investors and … policymakers trying to promote the efficiency of capital markets and national systems of innovation. Knut Blind, Berlin University … technological innovation has become a central issue in public policy, corporate finance and business management. This detailed book …